News

1. Marquis Who's Who Honors Shelly McCurry for Expertise in Entrepreneurship and Clinical Research

   Shelly McCurry recognized as the founder of Repress Therapeutics LLC

2. Marquis Who's Who Listee Kara Leigh Roncin, MD, Featured in the December 2025/January 2026 Issue of Forbes Magazine

   Kara Leigh Roncin, MD, shared her professional achievements and industry expertise in Forbes magazine

3. Adarsh K. Gupta, MD Named a 2026 Castle Connolly Top Doctor

   Adarsh K. Gupta, MD has been named a 2026 Castle Connolly Top Doctor, the 15th year he has received the esteemed Top Doctor designation.

4. Creative Bioarray Launches Comprehensive hERG Safety Assay Service to Enhance Drug Development

   In a significant stride towards facilitating safer and more effective drug development, Creative Bioarray is pleased to announce the launch of its flagship hERG safety assay service.

5. Creative Biogene Expands Plant Genetic Engineering Services to Meet Growing Industry Demands

   Creative Biogene is excited to announce the expansion of its comprehensive plant genetic modification service, which integrates cutting-edge gene editing technologies.

6. New Frontiers in Biomedicine: Creative Biolabs Advances Eukaryotic Microorganism Exosome R&D

   Creative Biolabs expands its exosome portfolio to include non-mammalian species, boosting vaccine and drug delivery innovation.

7. Creative Biolabs Pushes Into Next‑Gen Interaction Biology With Yeast Two‑Hybrid Platforms

   Creative Biolabs has rolled out a suite of yeast two‑hybrid (Y2H) technologies, aiming to give researchers a more flexible and scalable way to map protein networks inside living cells.

8. Creative BioMart Unveils Expanded Cytokine Collection to Advance Immunology Research

   Creative BioMart is pleased to announce the expansion of its cytokine product collection.

9. Creative Diagnostics Expands Portfolio of Products for Hepatic Metabolism to Accelerate In Vitro Drug Metabolism Studies

   Creative Diagnostics announces the expansion of its comprehensive range of Products for Hepatic Metabolism.

10. Ace Therapeutics Leads the Way in Advancing Hemorrhagic Stroke Research with Custom In Vitro and In Vivo Models

    Ace Therapeutics provides customized hemorrhagic stroke models and CRO services to empower researchers worldwide to unravel the complexities of ICH and accelerate the development of life-saving treatments.